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ANALYSIS OF DTC GENETIC FITNESS TESTS
Abstract
Based on current scientific literature, Direct-to-Consumer (DTC) genetic tests for fitness
capability generally lack validation and have little predictive value. We aimed to evaluate DTC
genetic fitness testing companies found through Google searches. Website information including
genes tested and claims made by the companies was collected. In total, thirty-one companies
were evaluated. Only 8 of 31 companies identify genes being tested and of these 8, only 4 cite
any scientific literature. The 6 most common genes tested (MCGT) were ACE, ACTN3, AGT,
FTO, IL6,  a nd PPARG. The 5 most common claims (MCC) were genetically tailored nutrition,
genetically tailored workout, information on injury risk, personalized fitness program, and
response to training. Given the lack of information provided by the companies, we cannot fully
assess the claims, and can only express skepticism about the limited value of such testing as per
the current scientific literature. Therefore, more research is needed to better understand genetic
differences associated with athletic traits for the benefit of consumers.
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Introduction
Since the first full sequencing of the human genome in 2003, the cost of genetic
sequencing has continuously decreased (Allyse, Robinson, Ferber, & Sharp, 2018). Decreasing
costs have resulted in the development of a new market sector, with companies selling genetic
information to consumers, using the internet as well as brick and mortar retail options (Harris,
Kelly, & Wyatt, 2013). This business model is known as direct-to-consumer (DTC) genetic
testing and manifests itself in a variety of products, such as ancestry testing, health testing and
carrier testing (Phillips, 2016).
One increasingly common type of DTC genetic test is trait testing for fitness capability;
however, genetic fitness tests generally lack validation and have little predictive value (Phillips,
2016). In the past, at-home saliva test kits were seen as commercial purchases rather than
medical tests, so informed consent was not required and “there were no clear regulatory
mechanisms in place to assess the analytical validity, clinical validity, and clinical utility”
(Allyse et al., 2018 p. 116). Without validation studies or supporting research, DTC genetic
testing companies have blazed their own trails in the scientific and business communities.
Regulation of DTC Genetic Tests
In 2010, the Food & Drug Administration (FDA) asserted its right to regulate DTC
genetic tests based on the 1976 Medical Device Amendments to the Food, Drug, and Cosmetic
Act. The FDA requested the companies apply for premarket approval and noted that they no
longer intended to exempt such tests from more stringent regulations. In a 2017 reassessment,
then FDA Commissioner Scott Gottlieb outlined a pathway for DTC genetic tests for genetic
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health risks to be evaluated and thus enter the marketplace upon approval, indicating the FDA’s
intention to differentiate between low risk, moderate risk and high risk genetic testing.
According to the FDA website, DTC genetic tests relating to athletic ability are a “low risk
general wellness product” and that they do not “generally” review these types of tests
(https://www.fda.gov/medical-devices/vitro- diagnostics/direct-consumer-tests, date accessed:
8/11/19). As labs performing DTC genetics tests are not being held to the same analytic
standards as other types of testing, the accuracy and reliability of such testing is questionable
(Lippi, Favaloro, & Plebani, 2011).
Marketing of DTC Genetic Tests
The argument has been made that DTC companies manipulate “consumer
identity-seeking” (Caulfield & McGuire, 2012, p. 28) by marketing the idea that a person’s
genetic construct determines much about them and that useful information can be drawn from
their DNA. False and overstated claims are frequently made in order to lure consumers, which
Murray et al (2010) describes as operating “under the protective cloak of legitimate science” (p.
459) and Spencer and Topol (2019) call “faux scientific authority” (p. 45).
The complexity of genetic testing and its implications makes it difficult to be confident
consumers are fully informed of the risks, benefits, and limitations of such testing (Hawkins &
Ho, 2012). Most traits are multifactorial and may be subject to epigenetic and environmental
effects, so that genetic testing provides results that are difficult to interpret and easily
misunderstood by consumers (Hawkins & Ho, 2012). As Harris et al states, “One common point
of concern is how individuals may (mis)understand, (mis)interpret and cope with the genetic
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information that they are provided from genetic tests not ordered through a healthcare
professional” (Harris et al., 2013, p. 277).
DTC Genetic Fitness Tests
At the beginning of 2016, Phillips reported that 246 companies were offering online
DNA tests, 38 of which were categorized as testing for athletics. The first known study of these
tests was published in 2013; the UK-based team of Williams, Heffernan, and Day (2014)
performed internet searches to identify 22 DTC genetic fitness tests then available to the public.
The genes most frequently tested for by these companies were polymorphisms in the ACTN3 (11
of 22 companies) and ACE (6 of 22 companies) genes - ACTN3 being tagged as the ‘speed gene’
since it had been identified as more common in speed and power sport athletes (Williams et al.,
2014). Williams et al. (2014) indicated that 9 of the 22 companies they looked at did not make
public information on which genetic variants were included in their test. DTC companies that do
not disclose which variants they assess have been criticized because they make it impossible for
academics or consumers to assess the test’s validity (Webborn et al., 2015).
Webborn et al. (2015) also conducted internet searches intended to imitate what a
potential consumer might do. The authors found that the relevance of genetic variants to
athleticism were not made clear on the websites and required subjective interpretation (Webborn
et al., 2015). The most commonly tested variant in these tests was ACTN3 R577X, and the second
most commonly tested variant was ACE I/D ( Webborn et al., 2015). Claims made by these
companies in the study on their websites were generally lacking in scientific support (Webborn
et al., 2015). Studies noted by companies that did provide citations were often not representative
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of the literature as a whole – something that likely would be difficult for customers to evaluate –
and variant interpretation was inconsistent across different companies (Spencer & Topol, 2019).
Genes of Interest for Fitness
There are a variety of genes of interest that play a role in athleticism and DTC genetic
fitness companies claim to use various subsets of these genes to predict athletic ability and
individual response to exercise. Some of the most frequently cited genes that appear to impact
athleticism are ACE, ACTN3, AGT, FTO, IL6, and PPARG.
ACE. The ACE gene plays a role in controlling blood pressure by regulating body fluid
levels (Puthucheary et al., 2011). Variants in ACE I have been implicated in exaggerated
response to training regimens, cardiac growth in response to a stimulus, and greater strength
gains in response to training (Puthucheary et al., 2011). Research shows mixed results in regards
to the significance of the I a nd D alleles. A meta analysis by Ma et al. (2013) found a significant
association between the I/I g enotype and endurance performance, whereas the D allele was
associated with strength and performance in power related events. Other smaller studies also
observed a higher frequency of the D allele among sprint type athletes (Nazarov et al., 2001;
Papadimitriou et al, 2016). However, the long distance runners in the Nazarov et al. (2001) study
had similar genotypes to controls, rather than a bias towards the I a llele as other studies had
observed. Two other studies involved elite endurance athletes from widely different sports such
as cycling, gymnastics, and hockey, and found no notable differences in genotype frequencies
between their athletes and controls (Rankinen et al., 2000; Taylor, Mamotte, Fallon, & Van
Bockxmeer, 1999).
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ACTN3. The ACTN3 gene codes for a protein found in fast-twitch muscle fibers that is
activated during short bursts of activity such as sprinting (Lee, Houweling, North, & Quinlan,
2016). North et al. (1999) first reported a relationship between athletic performance and the
R577X nonsense mutation, which is carried by approximately 20% of the world’s population
(Lee et al., 2016). It has been argued that the R allele is advantageous in power type events,
noting that in some studies the RR genotype is overrepresented in power athletes whereas the XX
genotype is associated with lower muscle strength and lower sprinting ability (Kikuchi &
Nakazato, 2015).
Alfred et al. (2011) concluded that the RR g enotype is more common among both sprint
and power athletes whereas Ma et al. (2013) found a significant association between the RR
genotype and power events only. Power athletes have also been found to be approximately 50%
less likely to have the XX g enotype (Eynon et al., 2012; Druzhevskaya, Ahmetov, Astratenkova,
& Rogozkin, 2008). In contrast, evidence for the association between the XX genotype and
endurance capability is weaker. One study found an underrepresentation of the XX g enotype
amongst endurance athletes; moreover, they found athletes with an RR g enotype outperformed
those with an RX g enotype in an endurance exercise (Ahmetov et al., 2010). Another study also
found no association between XX and endurance ability among Ironman Triathlon participants
(Saunders et al., 2007). Based on current literature, there appears to be more consistent data
supporting an association between ACTN3 power performance and less data supporting an XX
association with endurance performance (Guth & Roth, 2013).
AGT. According to Aleksandra et al, certain AGT p olymorphisms are associated with
sports performance. Higher levels of the angiotensin II protein, which is associated with
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improved power and strength performance, were seen in women who carried the C a llele when
compared to those with the TT genotype (Aleksandra et al., 2016). However, much of the
research onAGT relates to hypertension, methamphetamine dependence, and coronary heart
disease, and there is limited information on its relationship to athletic performance.
FTO. The FTO gene has been shown to relate to satiety, and appears to impact the
likelihood of obesity. One study focused on a population carrying the G allele at a particular SNP
and found it correlated with higher BMI (Scuteri, 2007). Another study surveyed children and
found those with two lower risk FTO alleles consumed significantly less food than those with
one or two higher risk alleles (Wardle, 2009). Some researchers also speculate that this gene is
implicated in athleticism; however, a study by Eynon et al (2013) surveyed athletes and found
the AT p olymorphism was not associated with elite athletic status.
IL6. The interleukin-6 gene regulates the body’s IL-6 levels, which are thought to be
associated with inflammatory diseases (Tanaka, 2014). The frequency of the G allele and GG
genotype of IL6 have been documented to be higher among power athletes relative to controls;
however, no difference in allele frequency has been seen between endurance athletes and
controls (Ruiz et al., 2010). Eynon et al. (2011a) analyzed IL6 g enotypes and found no
statistically significant differences amongst any groups and therefore stressed the need for
replication studies to fully understand any potential associations between specific alleles and
athletic status or performance.
PPARG. The PPARG g ene belongs to a family of Peroxisome Proliferator-Activated
Receptor (PPAR) genes, which have been shown to have an association with certain fitness
phenotypes (Leońska-Duniec, Ahmetov, & Zmijewski, 2016). The PPARG Alanine (Ala) a llele,
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compared to the Proline (Pro) a llele, was significantly more common in power athletes relative
to endurance athletes (Drozdovska, Dosenko, Ahmetov, & Ilyin, 2013). Leońska-Duniec et al.
(2016) found that those with the ProPro g enotype experienced a greater reduction in body fat
following an aerobic training program relative to Ala carriers; suggesting the Ala g enotype may
weaken the beneficial effects of such a training program. The Ala c arriers, on the other hand,
seemed to benefit more from resistance style training (Leońska-Duniec et al., 2016).
Opinions of Genetic Fitness Testing
With no regulation of DTC genetic fitness tests to provide quality assurance, expert
opinion on current genotype testing practices for fitness associated phenotypes is particularly
valuable. Mattsson, Wheeler, Waggott, Caleshu, and Ashley (2016) state that research supporting
genetic testing for sports is based on too small a sample size: study sizes need to be increased
and studies replicated so that what is reported is not overestimated. Given small homogenous
cohorts, the results cannot be extrapolated to the general population and should not be utilized in
such a way (Mattsson et al., 2016). Genome wide association studies (GWAS) looking for single
nucleotide polymorphisms, or SNPs, for athletic ability typically have small sample sizes
(N=100-200) as compared to GWAS studies looking into medical conditions such as
Alzheimer’s, which inherently limits the application to the general population (Eynon, Morán,
Birk, & Lucia, 2011b). Moreover, general research in the field has been performed on
Caucasian/European participants, thus making the extrapolation of the results more difficult for
the general population (Vlahovich et al., 2017b).
Other experts stress that the performance of an athlete is not based solely on his/her
genetics; rather, a multitude of genetic and non-genetic factors that make up ability (Brooks &

ANALYSIS OF DTC GENETIC FITNESS TESTS
Tarini, 2011). In one study, one hundred twenty known genetic alleles that play a role in athletic
performance were categorized into 77 endurance-related genetic markers and 43
power/strength-related genetic markers (Ahmetov & Fedotovskaya, 2015). Only 9% of the total
markers showed a genotype-phenotype relationship with athletic status in three or more studies
analyzed (Ahmetov & Fedotovskaya, 2015). Whatever benefit there may be from understanding
this complex genetic information via DTC genetic fitness testing, the lack of sufficient genetic
counseling available to consumers may present a further limitation (Vlahovich, Fricker, Brown,
& Hughes, 2017a; Webborn et al., 2015).
In regards to the ACTN3 genotype, Webborn et al. (2015) state, “Contribution to the
degree of inter-individual variability in sprinting performance is trivial” (p. 1490) which may
result in, as Murray et al. (2010) says, manipulation and subjected misuse of scientific
information. Caulfield (2011) emphatically states that even though there is an underlying basis
for testing for ACTN3 and fast-twitch muscle fibers, “It is wrong to imply that it is a test for
athletic ability, a complex, socially constructed and multi-factorial concept, or that it can provide
anything close to a definitive conclusion about future speed abilities” (p. 3). As Caulfield (2011)
notes, there will be athletes in the Olympics without the R577 variant and there will be people
with the R577 variant watching the Olympics from home.
Methods
In October 2019, two iterations of an internet search were conducted to identify
commercially available fitness and exercise related genetic tests. To mimic what a potential
consumer could find if interested in DTC genetic fitness testing, four English language internet
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search terms were typed into the internet browser www.google.com: GENETIC, TEST,
FITNESS, DNA. The websites found in the first ten pages of each search were recorded.
Each website was examined for the following information, if available: website address,
name of DTC company, name of the genetic fitness test, genes identified, scientific articles cited,
general marketing claims, if an FAQ section was present, cost of testing, if previous genetic
testing results could be imported, and if the company offered nutrition specific genetic testing.
Data points from each DTC company were entered into a spreadsheet for analysis. Thirty-four
companies were identified in total, including 3 companies that did not ship to the United States
and were subsequently excluded from analyses, giving a total of 31 companies assessed.
Descriptive statistics were employed to examine the type, frequency and evidentiary support of
claims on behalf of the DTC genetic fitness testing products, and (where possible) the genes
included for testing.
Results
In total, 31 companies were identified with websites that sold DTC genetic fitness tests in
the U.S. (Table 1). Of the 31 websites, 8 identified the genes tested, noted in bold. One hundred
forty-five unique genes were included in one or more of these 8 tests (Table 2). The genes ACE
(5), ACTN3 ( 7), AGT ( 6), FTO ( 7), IL6 (6), a nd PPARG (6) were the 6 most common genes
tested (MCGT) (Figure 1). Seven websites cited scientific literature while 24 did not (Figure 2).
Of the 7 websites, 2 websites had 2-5 articles, 1 website had 6-10 articles, and 4 websites had
11+articles. Only 4 of the 8 websites that identified genes cited any scientific literature (Table 1).
The 5 most common claims (MCC), seen in at least one third of the websites, were
genetically tailored nutrition ( 12), genetically tailored workout (17), information on injury risk
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(14), personalized fitness program (13), and response to training ( 11) (Figure 3). The cost of
DTC genetic fitness tests was an average of $182 and ranged from $20 to $399 (Figure 4). Two
companies with very low cost testing, Xcode and FoundMyFitness ($20 and $25 respectively),
required consumers to upload their own genetic data file from companies such as 23andme. Four
websites did not list a price for their test.
Table 1 - DTC Genetic Fitness Testing Companies Assessed

DTC
Company
Advanced
Genomic
Solutions

Website
ags-testing-kits.myshopify.co
m

Test Name

Genes
Literature
Identified? Identified?
(Y/N)
(Y/N)

NutraFit Health & Wellness
Genetic Test

N

N

CALIGENIX caligenix.com

Sports Nutrition

N

N

Circle DNA

circledna.com

Vital DNA Test

N

N

DNAFit

dnafit.com/us

Health Fit

Y

Y

dnaPower

dnapower.com

fitPower

N

N

DNA Code

dnacode.com

Fitness & Nutrition

N

N

Dnomium

dnomium.com

Fitness & Nutrition

N

N

Easy DNA

easydna.ie

NutriFit Health & Fitness
DNA Testing

N

N

Fitness
Genes

fitnessgenes.com

DNA Analysis

Y

N

Found My
Fitness

foundmyfitness.com

Found My Fitness
Comprehensive Report

N

N

Genetic
Direction

geneticdirection.com

GxPerform

Y

Y

Genovate

genovate.com

DNA Fitness Test

Y

N

GenoVive

genoviveusa.com

Nutrition and Fitness Genetic
Profile Report
N

Y

Fitness Panel

N

Health Codes
DNA
healthcodesdna.com

N
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Helix

helix.com

MyTraits Sport for iOS

N

N

HomeDNA

homedna.com

HomeDNA Healthy Weight Y

Y

IDLife

idlife.com

DNA Bundle

N

N

LifeDNA

lifedna.com

LifeDNA Reports + DNA
Kit

N

Y

MiaDNA

miadna.com

Exercise & Fitness

N

N

Molecular
Fitness

mtlfitness.com

Molecular Fitness

N

Y

myDNA

mydna.life/en-us

Nutrition & Fitness

Y

Y

MyExome

myexome.com

DNA Testing for Fitness,
Nutrition and Health

N

N

Myogenes

myogenes.com

Diet, Health & Fitness Test

N

N

New Life
Genetics

newlifegenetics.com

DNA Fitness Test for Men,
DNA Fitness Test for
Women
Y

N

Next Health

next-health.com

Genetic Fit Testing

N

N

Ori

askori.com

OriFIT + Package

N

N

Orig3n

shop.orig3n.com

Fitness DNA Test

Y

N

Original Gene originalgene.com

Fitness & Healthy Living
DNA Test

N

N

Vitagene

vitagene.com

Health Plus Ancestry Report N

N

Vitl

vitl.com

DNA Nutrition Test

N

N

Xcode

xcode.life

Gene Fitness Report

N

N

Table 2 - All Genes Identified by DTC Genetic Fitness Testing Websites
ABCB11

CKM

GLIS1

LRRN6C

PPARG

ACE

CLOCK

GNB3

MAP2K5

PPARGC1

ACTG1

CNTF

GNPDA2

MBL2/DKK1

PPM1K

ACTN3

COL1A1

GPRC5B

MC4R

PRKD1

ACVR1B

COL5A1

GPX1

MCT1

QPCTL-GIPR

ADH1C

COMT

GSTM1

MEPE

RP11-10017.3-0
01

ADIPOQ

CREB1

GSTT1

MGMT

RPL27A
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ADORA2A

CRP

HERC2

MSTN

SEC16B

ADRB2

CRP

HIF1A

MSTNRARE

SHBG1

ADRB2_1

CRY2

HLA

MTCH2

SHBG2

ADRB2_2

CYP1A1

HLA

MTHFR

SHBGE7

ADRB3

CYP1A2

HNF1A

MTHFR_SNP2

SLC23A1

AGT

CYP2R1

HOXB3

MTIF3

SLC25A13

AHR

DEC(1)

IGF1

MTNR1B

SLC30A8

AKT1

DRD2

IGF1_2

MTR

SLC39A8

ALDH2

EC16B

IGFBP3

MTRR

SLC8A1

AMPD1

EDN1

IGFS9B

NADSYN1

SOD2

ANNK1

EPHX1

IL15RA

NBPF3

SPTBN1

APOA2

ERP27

IL6

NEGR1

SYT1

APOA5

ETV5

IL6R

NFE2L2

TCF7L2

APOC1
(APOE-CI-CII)

FABP2

IRS1

NMB

TFAP2B

APOC3

FAIM2

KANSL1

NOS3

TGFA

APOE

FANCL

KIF5B

NRF2

TNF

ARID3B

FLJ35779

LCT

NRXN3

TRHR

BCM01

FTO

LIPC

PEX14

UCP2

BDKRB2

FUT2

LPL

PGC1A

UCP3

BDNF

GBF1

LRP1B

POLD3

VDR

C18orf19

GC

LRP5

PPARA

VDR_Taq

CAT

GDF5

LRPPRC

PPARD

VEGF/VEGFA
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Figure 1 - Percentages of the 8 DTC Genetic Fitness Testing Companies that List MCGT

Figure 2 - Percentages of DTC Genetic Fitness Testing Companies Citing Scientific
Literature
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Figure 3 - Top Claims of DTC Genetic Fitness Testing Companies

Figure 4 - Cost of DTC Genetic Fitness Tests
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Discussion
Our analysis showed that of 31 DTC genetic fitness tests found online, only 8 companies
attempted to inform consumers on what genes were included in the test. Without knowledge of
what genes are being examined, no consumers and no experts can assess the value of the tests for
sale from those 23 companies, many of which carry a substantial price tag. Among those 8 that
do list the genes examined, only half offered any references to scientific literature to support
their choice of targets. Further consideration of the utility of testing, therefore, was only possible
for four companies that provided both the genes tested and literature to support a scientific
rationale for testing.
Genetic Direction. All of the 6 MCGT are tested here; however, literature was supplied
only for ACE, ACTN3, AGT, and IL6. The study available (Weyerstraß, Stewart, Wesselius, &
Zeegers, 2018) on the website concluded that there is an association between being a power
athlete and certain alleles; yet, the authors also suggest that more research is needed on these
genes to come to any comprehensive conclusions. Despite this caveat, Genetic Direction still
makes 3 of the 5 MCC: genetically tailored workout, personalized fitness program, and training
response.
HomeDNA. Of the 6 MCGT, HomeDNA only looks at FTO a nd PPARG and which,
surprisingly, was noted to not make the claim of genetically tailored nutrition. Instead, the MCC
made are genetically tailored workout and personalized fitness program. Noted researcher Dr.
Mark Sarzynski is credited for his research efforts for HomeDNA, but he is also part of the
Genetic Direction leadership team.
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myDNA. Five of the MCGT are offered by myDNA: ACTN3, AGT, FTO, IL6 and
PPARG. Scientific literature available on the site mentions ACTN3 (Kikuchi & Nakazato, 2015),
AGT ( Zarebska et al., 2013), and IL6 ( Ruiz et al., 2010), among others, for muscle fiber
composition as well as a study showing the absence of any association between certain
genotypes and sprint/power performance (Ahmetov, Vinogradova, & Williams, 2012).
Importantly, myDNA is the only website to list two employed associate genetic counselors on
their team, but their scope of practice is not discussed.
The MCC genetically tailored nutrition, information on injury risk, and personalized
fitness program are made; furthermore, statements are made about the gene variants that myDNA
tests for but the specific variants are not stated. For example, myDNA calls ACTN3 ‘The Power
Gene’ and incorrectly states that elite athletes will generally possess the variant of this gene
associated with explosive fitness movements. It is true that there is an association between elite
power athletes and the RR g enotype for explosive movements; yet, not all elite athletes will have
the RR g enotype nor will every sport call for the use of fast-twitch muscle fibers. AGT i s called
‘The Strength Gene’ and there have been claims that the associated genetic variant is most
commonly found in power sport Olympians, but this has not been verified. IL6 i s called ‘The
Recovery Gene’ and there have been claims that the associated genetic variant helps the body
recover faster from intense exercise, and while this is plausible, it has not been documented in
the literature in studies of athletes. FTO a nd PPARG a re related to food satiety and fat storage,
respectively, and are described as much on myDNA’s website with marketing claims such as the
FTO g ene may be the reason why someone goes back for seconds at the dinner table.
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DNAfit. All of the 6 MCGT are mentioned on the website and scientific references are
present, the latest from 2019 (Pickering et al.). Authors of the literature cited included two
employees of DNAfit: Dr. Ildus Ahmetov and Dr. Silvia Camporesi from DNAfit’s Scientific &
Advisory Team. It is not indicated when Dr. Ahmetov or Dr. Camporesi became employees of
DNAfit or if their publications were done prior or after that relationship was established.
The MCC of genetically tailored workout, information on injury risk, personalized fitness
program, and response to training are made, and akin to myDNA, these claims are tied to the
genes that DNAfit tests for. This time, however, actual alleles are discussed in such a way to aid
consumers who are interested in assessing their genetic basis workout recommendations.
According to DNAfit, the I a nd D alleles of ACE a re the basis of different workout
recommendations: the I/I alleles associated with endurance sports and high repetition weight
training programs and the DD alleles associated with power based training. These findings have
been seen in the literature but are not without controversy, as some studies showed no significant
effect of the II alleles in endurance training. DNAfit makes claims about ACTN3 while
incorrectly labeling the alleles they are looking at, identifying the RR and XX a lleles as CC and
TT, respectively. The claim made here of the XX g enotype being found more frequently in
endurance athletes is not supported in the literature, while the claim that people with the RR
genotype are likely to see increased benefit from explosive training is more extensively
supported. Claims that AGT alleles are associated with power and strength sports and IL6 a lleles
with inflammatory responses are supported by literature. Additionally, claims for alleles
associated with fat sensitivities from FTO and PPARG are relatively well supported by the
literature as well.
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Study Limitations
This study examined only the information available to a consumer before a test is
purchased. Purchasing tests from a sample of DTC genetic fitness companies would have
permitted us to assess how results are presented and what explanatory information is available
and how that compares to relevant scientific literature.
Practice Implications
Our study suggests that those purchasing these tests for recreational purposes should be
aware that the tests, often expensive, provide almost entirely inconclusive results. Ideally,
consumers may be made aware that all DTC companies are not created equal and this study may
provide a helpful guide for their own research and comparison shopping. Additionally, this work
may provide genetic counselors with an up to date reference for answering questions about the
types and limitations of genetic fitness tests.
Research Recommendations
More scientific research is still needed to better understand genetic differences associated
with athletic traits. It appears there is a consensus in the scientific community regarding the
inherent predictive limitations of the current data on polymorphisms related to
athletics—including the most well established as well as the more controversial associations.
Larger, racially diverse cohorts are needed as well as cohorts with varying athletic levels, from
people who do not work out at all to those who are not elite athletes, but workout three to five
times per week. DTC genetic fitness testing for athletic ability may eventually play a useful role
in an assessment of fitness potential. However, the scientific community is rightly concerned
about the legitimacy of what companies are marketing and selling the consumer as representing
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the general population (as opposed to elite athletes). Given the lack of basic information
available on the websites, we cannot fully assess the basis of their claims, and can only generally
express skepticism about the product as being limited in value according to what is currently
known. DTC genetic testing companies should be encouraged to be more honest and transparent
in reporting what their tests cover and what the results may mean for each individual.
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